(Q28217356)

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Direct-reacting bilirubin, bilirubin glucuronide, in serum, bile and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

The excretion of bilirubin as a diglucuronide giving the direct van den Bergh reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Uridine compounds in glucuronic acid metabolism. I. The formation of glucuronides in liver suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Congenital jaundice in rats, due to a defect in glucuronide formation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

The synthesis of bilirubin glucuronide in animal and human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

1 reference

7 January 2021

The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

A Biochemical Lesion in Congenital, Non-obstructive, Non-hæmolytic Jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Substrates and products of purified rat liver bilirubin UDP-glucuronosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Effects of phenobarbital on bilirubin metabolism and its response to phototherapy in the jaundiced Gunn rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Oral calcium phosphate: a new therapy for Crigler-Najjar disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Gene therapy for inherited hyperbilirubinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

[Prevalence of Gilbert's syndrome in Germany]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Bilirubin glucuronide formation in vitro; demonstration of a defect in Gilbert's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Hepatic Bilirubin UDP-Glucuronyl Transferase Activity in Liver Disease and Gilbert's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Unconjugated Bilirubin and an Increased Proportion of Bilirubin Monoconjugates in the Bile of Patients with Gilbert's Syndrome and Crigler-Najjar Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Detection of Gilbert's syndrome in patients with hemolysis. A method using radioactive chromium.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Predicted homozygous mis-sense mutation in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

The genetic basis of Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Bilirubin is an antioxidant of possible physiological importance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Serum bilirubin and risk of ischemic heart disease in middle-aged British men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

In vitro induction of bilirubin conjugation in primary rat hepatocyte culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Gilbert syndrome associated with beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Alteration of drug metabolism in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Endogenous hormones and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Kinetics and metabolism of paracetamol and phenacetin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Mechanism of indinavir-induced hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

Reversible acute haemolysis associated with indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900359-8

7 January 2021

10.1016/S0168-8278(02)00359-8

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12480568

1 reference

Consolidated OpenCitations Corpus – April 2017